Cerebrovascular reactivity: Role of endothelium/platelet/leukocyte interactions

Cerebrovascular and Brain Metabolism Reviews

Volumn 8, Issue 1, 1996, Pages 11-94

  Akopov, S ^a   Sercombe, R ^a   Seylaz, J ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN CIRCULATION; HUMAN; LEUKOCYTE; PHYSIOLOGY; REVIEW; THROMBOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PLATELETS; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOCYTES;

EID: 0030111342     PISSN: 10408827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (432)

1. Abe K, Ohta S, Komiya T, Sakamoto N, Mizuno Y. Fibromuscular dysplasia complicated by primary thrombocythemia presenting recurrent ischémie cerebrovascular accidents: a case report. Jpn J Med 1990;29:548-54.
2. Abu Rahma AF, Boland JP, Robinson P, Decanio R. Antiplatelet therapy and carotid plaque hemorrhage and its clinical implications. J Curdiovasc Surg (Torino) 1990;31:66-70.
3. Adams HP, Gross CE. Embolism distal to stenosis of the middle cerebral artery. Stroke 1981;12:228-9.
4. AhnYS, Harrington WJ. Calcium channel blockers in thrombotic diseases. Adv Intern Med 1987;32:137-54.
5. Akopov SE. Blood cells interaction and antiplatelet therapy: a review. Drugs Today 1992;28:405-20.
6. Akopov SE. Intravascular platelet activation depending on degree of stenosis of major cranial arteries in patients with atherosclerosis. Blood Coag Fibrinol 1992;3:679-80.
7. Akopov SE, Balayan BG, Gabrielian ES. Comparison of vasodilator effects on human middle cerebral artery constriction induced by vasoconstrictors or activated platelets. Methods Find Exp Clin Pharmacol 1992;14:437-9.
8. Akopov SE, Gabrielian ES. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination. Eur J Clin Pharmacol 1992;42:257-9.
9. Akopov SE, Gabrielian ES. The relationship between the degradation of prostacyclin in blood and antiplatelet drug effects in patients with atherosclerosis. J Clin Pharmacol 1993;33:1048-51.
10. Akopov SE, Ghazarian Ay Gabrielian ES. Effects of nimodipine and nicergoline on cerebrovascular injuries induced by activation of platelets and leukocytes in vivo. Arch Int Pharmacodyn Ther 1992;318:66-75.
11. Akopov SE, Grigorian MR, Gabrielian ES. Effects of drugs on platelet and neutrophil aggregation depending on their interaction. Methods Find Exp Clin Pharmacol 1991;13:591-4.
12. Akopov SE, Grigorian MR, Gabrielian ES. The endothelium-dependent relaxation of human middle cerebral artery: effect of activated neutrophils. Experientia 1992;48:34-6.
13. Akopov S, Grigorian G, Gabrielian E. Nonivasive testing of dynamic component of internal carotid artery stenosis in patients with chronic cerebrovascular disease. Angiology 1994;45:125-30.
14. Akopov SE, Grigorian MR, Gabrielian ES, Balayan BG. Investigation of the dependence of human middle cerebral artery contractile activity on the presence of an atherosclerotic patch. Heart Vessels 1992;7:196-9.
15. Akopov SE, Sercombe R, Seylaz J. Endothelial dysfunction in cerebral vessels following carotid artery infusion of phorbol ester in rabbits: the role of polymorphonuclear leukocytes. J Cereb Blood Flow Metab 1994;4:1078-87.
16. Akopov SE, Sercombe R, Seylaz J. Leukocyte-induced endothelial dysfunction in the rabbit basilar artery: modulation by platelet activating factor. J Lipid Mediators 1995; 11:267-79.
17. Akopov SE, Sercombe R, Seylaz J. Actions of platelet activating factor on isolated rabbit basilar artery: modulation by activated polymorphonuclear leukocytes. J Vase Res 1995;32:49-57.
18. Akopov SE, Sercombe R, Seylaz J. Leukocyte-induced acute endothelial dysfunction in middle cerebral artery in rabbits: responses to aggregating platelets. Stroke 1994;25:2246-52.
19. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (EndoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol 1991;! 14:1059-68.
20. Albertine KH, Weyrich AS, Ma XL, Lefer DJ, Becker LC, Lefer AM. Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J Leukocyte Biol 1994;55:557-66.
21. Aliev G, Cirillo R, Salvatico E, Paro M, Prosdocimi M. Changes in vessel ultrastructure during ischemia and reperfusion of rabbit hindlimb: implications for therapeutic intervention. Microvasc Res 1992;46:65-76.
22. Alloatti G, Montrucchio G, Camussi G. Prostacyclin inhibits the platelet-dependent effects of platelet-activation factor in the rabbit isolated heart. J Cardiovasc Pharmacol 1990; 15:745-51.
23. AI-Mefty O, Marano G, Rajaraman S, Nugent R, Rodman N. Transient ischémie attacks due to increased platelet aggregation and adhesiveness. J Neurosurg 1979;50:449-53.
24. Anderson ML, Smith DS, Nioka S, Subramanian H, Garcia JH, Halsey JH, Chance B. Experimental brain ischemia: assessment of injury by magnetic resonance spectroscopy and histology. Neural Res \990; 12:195-204.
25. Asada Y, Hayashi T, Sumiyoshi A. Vascular injuries induced by materials released from platelet rich thrombosis in vito. Atherosclerosis 1988;70:1-6.
26. Badimon L, Badimon JJ, Fuster V. Thrombogenesis and inhibition of platelet aggregation. Experimental aspects and future approaches. ZKardiol 1990;79(suppl 3):133-45.
27. Barone FC, Hillegass LM, Price WJ, White Rf, Lee EV, Feuerstein GZ, Sarau H, Clark RK, Griswold DE. Polymorphonuclear leukocyte infiltration into cerebral focal ischémie tissue: myeloperoxidase activity assay and histologie verification. JNeurosci Res 1991;29:336-45.
28. Bassenenge E. Tonus epicardialer lietungsarterien and dynamische sténose. ZKardiol 1984;73:55-62.
29. Bax WA, Renzenbrink GJ, van der Linden EA, Zijlstra FJ, van Heuven-Nolsen D, Fekkes D, Bös E, Saxena PR. Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery. Circulation 1994;89:623-9.
30. Bazzoni G, DaJana E, Del Maschio A. Platelet-neutrophil interactions: possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991;76:491-9.
31. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sei USA 1990;87:162(M.
32. Bednar MM, Raymond S, McAuliffe T, Lodge PA, Gross CE. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke 1991;22:44-50.
33. Bellucci S, Ignatova E, Jaulet N, Boffa MC. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF. Thromb Haemost 1993;70:736-42.
34. Benassi G, Ricci P, Calbucci F, Caccinatore FM, D'Alessandro R. Slowly progressive ischémie stroke as first manifestation of essential thrombocythemia. Stroke 1989;20:1271~2.
35. Bernard C, Szekely B, Philip I, Wollman E, Payen D, Tedgui A. Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. J Clin Invest 1992:89:851-60.
36. Bernard C, Tedgui A. Cytokine network and the vessel wall. Insights into septic shock pathogenesis. Eur CytokineNetw 1992;3:19-33.
37. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA. Identification of an inducible adhesion molecule. Proc Natl Acad Sei USA 1987;84:9238-42.
38. Bienvenue K, Rüssel J, Granger DN. Leukotriene B4 mediates shear rate-dependent leukocyte adhesion in mesenteric venules. Circ Res 1992;71:906-11.
39. Bienvenue K, Rüssel J, Granger DN. Platelet-activating factor promotes shear rate-dependent leukocyte adhesion in postcapillary venules. JLipid Mediators 1993;8:95-103.
40. Bo P, Cosi V, Taccola A, Romani A, Savoldi F. EEG changes and platelet aggregation in experimental cerebral focal ischemia in rabbits. Boll Soc Irai Biol Sper 1991;67:71-5.
41. Bonvento G, Lacombe P. Serotonin and the cerebral circulation. In: Phillis JW, tä.The regulation of cerebral blood flow. Boca Raton: CRC Press, 1993:97 -111.
42. Born GVR. Haemorheological influences on platelet thrombogenesis. Clin Haemorheol 1985;5:891-905.
43. Born GVR. Aspirin and platelets in relation to cerebrovascular disease. Stroke 1990;21(suppl 12):29-31.
44. Born GVR. Coronary thrombosis: pathogenesis and prevention. Adv Exp Med Biol 1990;281:355-9.
45. Born GVR, Gross Ml Platelet aggregation induced by ADP in humans. Nature 1963;197:974-6.
46. Bornstein NM, Norris JW. Evolution and management of asymptomatic carotid stenosis. Cerebrovasc Brain MetabRev 1993;5:301-13.
47. Braquet P, Tougui L, Shen T-Y, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97-145.
48. Bussolino F, Alessi D, Turello E, Camussi G. Role of platelet activating factor in the adhesion process of polymorphonuclear leukocytes to endothelial cells. Adv Exp Med Biol 1991;297:55-64.
49. Candeias LP, Patel KB, Stratford MRL, Wardman P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species Superoxide anion and hypochlorous acid. FEES Lett 1993;333:151-3.
50. Cantor EH, Ho EH, Botelho LHP, Lumma WC, Rubanyi GM. Effect of nitric oxide, SIN-1, adenosine and iloprost on human polymorphonuclear leukocytes. In: Rubanyi GM, Vanhoutte PM, eds. Endothelium-derived relaxing factors. Basel: Karger, 1990:237-43.
51. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
52. Carpenter LJ, Johnston KJ, Kunkel RG, Roth RA. Phorbol myristate acetate produces injury to isolated rat lungs in the presence and absence of perfused neutrophils. Toxicol Appl Pharmacol 1987;91:22-32.
53. Claesson HE, Haeggstrom J. Human endothelial cells stimulate leukotriene synthesis and convert granulocyte released leukotriene A4 into leukotrienes B4, C4, D4 and E4. Eur J Biochem 1988; 173:93-100.
54. Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of central nervous system ischémie injury in rabbits using leukocyte adhesion antibody treatment. Stroke 1991 ;22:877-83.
55. Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of central nervous system ischémie injury by monoclonal antibody to intercellular adhesion molecule. J Neurosurg 1991 ;7'5:623-7.
56. Clower BR, Yoshioka J, Honma Y, Smith RR. Blood platelets and early intimai changes in cerebral arteries following experimental subarachnoid hemorrhage. In: Wilkins RH, ed.Cerebral angiospasm. New York: Raven Press, 1988:335-412.
57. Cocks TM, Malta E, King SJ, Woods RL, Angus JA. Oxyhemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 1991 ; 196:177-82.
58. Cofier E, Delsutier D, Couedic J-P, Chignard M, Benveniste J. Activated human platelets and neutrophils cooperate for the formation of PAF-acether (platelet-activating factor). Thromb Haemost 1987;58:21.
59. Conti P, Cifone M, Alesse E. Effect of supernatants from PHA-stimulated and non-stimulated lymphocyte cultures on thromboxane B release by polymorphonuclear leukocytes in vitro. Agents Actions 1985;16:52-4t.
60. Créa F, von Arnim T, Allwork S, Thompson GR, Maseri A. Failure of experimental atherosclerosis to sensitize coronary arteries to spasm in hypercholesterolemic rabbits. Am Heart.I 1985;109:491-7.
61. Croft KD, Berlin LJ, Vandongen R, Rouse I, Masarei J. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolemia. Atherosclerosis 1990;83:101-9.
62. Csaki C, Szabo C, Benyo Z, Reivich M, Kovach AG. Activated neutrophils inhibit cerebrovascular endothelium-dependent relaxation in vitro. Life Sei 1991;49:1087-94.
63. Damtew B, Goldsmith G, Tserng KY, Spagnuolo PJ. Human neutrophil adhesion to bovine aortic endothelium. Evidence for endothelial lipoxygenase activity. J Leukocyte Biol 1993;53:619-29.
64. Damtew B, Spagnuolo PJ. Platelet-activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase-dependent mechanism. Inflammation 1992;16:425-36.
65. Darius H, Grodzinska L, Meyer J. The effect of the nitric oxide donors molsidomine and SIN-1 on human polymorphonuclear leukocyte function in vitro and ex vivo. Eur J'Clin Pharmacol 1992;43:629-33.
66. Davies MG, Hagen PO. The vascular endothelium. A new horizon. Ann Surg 1993;218:593-609.
67. Dawson TM, Lavi E, Raps EC, Goldberg HI. Thrombotic microangiopathy isolated to the central nervous system. Ann Neural 1991;30:843-6.
68. Debdi M, Seylaz J, Sercombe R. Early changes in rabbit cerebral artery reactivity after subarachnoid hemorrhage. Stroke 1992;23:1154-62.
69. Debdi M, Seylaz J, Sercombe R. Increased influence of calcium and nicardipine on rabbit basilar artery reactivity after brief subarachnoid hemorrhage. J Cardiovasc Pharmacol 1993;21:755-9.
70. De Gaetano G, Evangelista V, Rajtar G, Del Mashio A, Cerletti C. Activated polymorphonuclear leukocytes stimulate platelet function. Thromb Res 1990; 11:25-32.
71. DeGrootPG, SixmaJJ. Platelet adhesion. Br JHaematol 1990;75:308-12.
72. De Kimpe SJ, van Heuven-Nolsen D, Nijkamp FP. Bovine polymorphonuclear leukocytes increase sensitivity to noradrenaline in isolated mesenteric arteries. Br J Pharmacol 1992; 105:581-6.
73. De Kimpe SJ, Van Heuven-Nolsen D, Nijkamp FP. Acstylcholine-induced relaxation in bovine isolated mesenteric arteries is suppressed by polymorphonuclear leukocytes. BrJ Pharmacol 1993;109:8-13.
74. Del Zoppo CJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991;22:1276-83.
75. De Nucci GF, Thomas F, D'Orléans-Juste P. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc NatlAcadSci USA 1989;85:9797-800.
76. Descombes JJ, Devys M, Laubie M, Verbeuren TJ. Endothelial thromboxane production plays a role in the contraction caused by 5-hydroxytryptamine in rat basilar arteries. Eur J Pharmacol 1993; 193-9.
77. Dietrich WD, Dewanjee S, Prado R, Watson BD, Dewanjee MK. Transient platelet accumulation in the rat after common carotid artery thrombosis. Stroke 1993;24:1534-40.
78. Dietrich WD, Prado R, Halley M, Watson BD. Microvascular and neuronal consequences of common carotid artery thrombosis and platelet embolization in rats. JNeuropathol Exp Neural 1993:52:351-60.
79. Dietrich WD, Prado R, Watson BD. Photochemically stimulated blood-borne factors induce blood-brain barrier alterations in rats. Stroke 1988;19:857-62.
80. Dietrich WD, Prado R, Watson BD, Busto R, Ginsberg MD. Hemodynamic consequences of common carotid artery thrombosis and thrombogenically activated blood in rats. J Cereb Blood Flow Metab 1991;ll:957-65.
81. Dinerman J, Mehta J, Lawson D, Mehta P. Enhancement of human neutrophil function by platelets: effects ofindomethacin. Thromb Res 1988;49:509-17.
82. Dohi Y, Boulanger CM, Hahn AWA, Buhler FR, Lusher TF. Endothelin stimulated by angiotensin II augments vascular contractility of hypertensive resistance arteries. Hypertension 1992; 19:131-7.
83. Domingo MT, Spinnewyn B, Chabrier PE, Braquet P. Changes in [3H]PAF binding and PAF concentration in gerbil brain after bilateral common carotid artery occlusion: a quantitative autoradiographic study. Brain Res 1994;640:268-76.
84. Dougherty JH, Levy DE, Weksler BB. Experimental cerebral ischemia products platelet aggregates. Neurology 1979;29:1460-5.
85. Dutka AJ, Korchanek PM, Hallenbeck JM. Influence of granulocytopenia on canine cerebral ischemia induced by air embolism. Stroke 1989;20:390-5.
86. Dzau VJ, Ganzales D, Kaempfer C, Dubin D, Wintroub BU Human neutrophils release serine proteases capable of activating prorenin. Circ Res 1987;60:595-601.
87. Ea Kim L, Javellaud J, Oudart N. Endothelium-dependent relaxation of rabbit middle cerebral artery to a histamine H3-agonist is reduced by inhibitors of nitric oxide and prostacyclin. Br J Pharmacol 1992; 105:103-6.
88. Ea Kirn L, Sercombe R, Oudart N. Relaxation of rabbit middle cerebral arteries in vitro by H, histaminergic agonists is inhibited by indomethacin and tranylcypromine. Fundam Clin Pharmacol 1988;2:463-75.
89. Eidt JF. Allison P, Noble S, Ashton JH, Golino P, McNatt J, Buja LM, Willerson JT. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 1989;84:18-25.
90. Elferink JG, Boonen CJ, de Koster BM. The role of calcium in neutrophil migration: the effect of calcium and calcium antagonists in electroporated neutrophils. Biochem Biophys Res Commun 1992;182:864-9.
91. Eliasziw M. Streifler JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJM. Significance of plaque ulcération in symptomatic patients with high-grade stenosis. Stroke 1994;25:304-8.
92. Elliot MJ, FinnAHR. Interactions between neutrophils and endothelium. Ann Thorac Surg 1993;56:1503-8.
93. Esmon CT. Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 1993;9:l-26.
94. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs microcirculation. Am J Physio! 1991;261:H 1038-42.
95. Faraci FM. Regulation of the cerebral circulation by endothelium. Pharmacol Ther 1992;56:l-22.
96. Faraci FM. Endothelium-derived vasoactive factors and regulation of the cerebral circulation. Neuwsurgery 1993;33:648-59.
97. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke 1994;25:692-703.
98. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 1990;66:8-17.
99. Faraci FM, Heistad DD. Endothelium-derived relaxing factor inhibits constrictor responses of large cerebral arteries to serotonin. J Cereb Blood Flow Metab 1992; 12:500-6.
100. Faraci FM, Lopez AG, Breese K, Armstrong ML, Heistad DD. Effect of atherosclerosis on cerebral vascular responses to activation of leukocytes and platelets in monkeys. Stroke 1991 ;22:790-6.
101. Faraci FM, Mayhan WG, Heistad DD. Responses of rat basilar artery to acetylcholine and platelet products in vivo. Stroke 1991;22:56-60.
102. Faraci FM, Williams JK, Breese KR, Armstrong ML, Heistad DD. Atherosclerosis potentiates constrictor responses of cerebral and ocular blood vessels to thromboxane in monkeys. Stroke 1989;20:242-7.
103. Feldman RL. Coronary thrombosis, coronary spasm and coronary atherosclerosis and speculation on the link between unstable angina and acute myocardial infarction. Am J Cardiol 1987;59:1187-90.
104. Feuerstein G, Yue T-L, Lysko PG. Platelet-activating factor: a putative mediator in central nervous system injury. Stroke 1990;21(suppl III):III90-4.
105. Fieshi C, Volante F, Battistini N, Zanette E, Passero S. Animal model of TIA: an experimental study with intracarotid ADP injection in rabbits. Stroke 1975;6:617-21.
106. Figols J, Cervos-Navarro J, Sampaolo S, Ferszt R. Microthrombi in the development of ischémie irreversible brain infarct. In: Cervos-Navarro J, Ferszt R, eds. Stroke and microcirculation. New York: Raven Press, 1987:69-74.
107. Filep JC, Foldes-Filep E. Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophils granulocytes. Eur J Pharmacol 1990; 190:67-73.
108. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 1992;85:1927-38.
109. Folts J. An in vivo model of experimental arterial stenosis, intimai damage, and periodic thrombosis. Circulation 1991;83(supplIV):IV3-14.
110. Forsterman U, Mugge A, Bode SM, Frolich JC. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res 1988;63:306-12.
111. Fredriksson K, Rosen I, Johansson B, Wieloch T. Cerebral platelet thromboembolism and thromboxane synthetase inhibition. Stroke 1985; 16:800-6.
112. Frerichs KU, Feuerstein G. Platelet-activating factor-key mediator in neuroinjury? Cerebrovasc Brain Metab Rev 1990;2:148-60.
113. Freudenberg H, Lichten PR. The normal wall segment in coronary stenoses: a postmortem study. ZKardiol 1981;70:863-9.
114. Friberg L, Olsen TS. Cerebrovascular instability in a subset of patients with stroke and transient ischémie attack. Arch Neural 1991;48:1026-31.
115. Fujimoto T, Suzuki H, Tanoue K, Fukushima Y, Yamazaki H. Cerebrovascular injuries induced by activation of platelets in vivo. Stroke 1985;16:245-51.
116. Furchgott RF, Zawadski JV The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
117. Furie MB, Naprstek BL, Silverstein SC. Migration of neutrophils across monolayers of cultured microvascular endothelial cells. J Cell Sei 1987;88:161 75.
118. Furlow TW, Bass NH. Stroke in rats produced by carotid injection of sodium arachidonate. Science 1975;187:658-60.
119. Futrell N. An improved photochemical model of embolie cerebral infraction in rats. Stroke 1991;22:225-32.
120. Futrell N, Garcia JH, Peterson E, Millikan C. Embolie stroke in aged rats. Stroke 1991;22:1582-91.
121. Futrell N, Riddle LM. The ultrastructure of photochemically induced thrombi with embolization in a rat model. Stroke 1993;24:1983-92.
122. Futrell N, Watson BD, Dietrich WD, Prado R, Millikan C, Ginsberg MD. A new model of embolie stroke produced by photochemical injury to the carotid artery in the rat. Ann Neural 1988:23:251-7.
123. Gaboury J, Woodman RC, Granger DN, Reinhard! P, Kubes P. Nitric oxide prevents leukocyte adherence: role of Superoxide. Am J Physiol 1993;265:H862-7.
124. Gabrielian ES, Akopov SE. Prostacyclin and cerebral circulation. Proc. IUPHAR 9th Int. Congress of Pharmacology, London, 1984;3:7-15.
125. Gabrielian ES, Akopov SE. Some aspects of the pharmacological regulation of the blood-vascular wall system. In: Medvedev 0, ed. Sov Med Rev A Cardiology, vol 3. London: Gordon & Brich, 1990:55-79.
126. Gabrielian ES, Akopov SE, Amroyan EA. Circulatory homeostasis of the brain: neuro-pharmacologic aspects of hematovasal regulation. In: Valdman A, ed. Sov Med Rev G Neuropharm. London: Gordon & Brich, 1990:171-95.
127. Gabrielian ES, Akopov SE, Ghazarian AV. Cerebral-artery spasm in vitro. Lancet 1990;335:115.
128. Gabrielian ES, Akopov SE, Grigorian MR, Toumasian KS. Cerebrovascular injuries induced by activation of platelets and leukocytes in vivo and their correction by neurotropin. Jpn J Pharmacol 1992:60:51-4.
129. Gamble JR, Vadas MA. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor beta. Science 1988;242:97-9.
130. Gardiner SM, Bennett T. Endothelial-derived relaxing factors: focus on nitric oxide. In: Vascular innervation and receptor mechanisms: new perspectives. New York: Academic Press, 1993:41-85.
131. George IN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Eng! J Med 1991:324:27-39.
132. Geraghty JJ, Hoch DB, Robert ME, Vinters HV Fatal puerperal cerebral vasospasm and stroke in a young woman. Neurology 1991;41:1145-7.
133. Germann P, Laher I, Bevan JA. Platelets augment rabbit cerebral artery constriction by activating protein kinase C. Stroke 1991:22:1534-40.
134. Gertler JP, Abbott WM. Prothrombotic and fibrinolytic function of normal and perturbed endothelium. J Surg Res 1992;52:89-92.
135. Ghods M, Mangal R, Iskandarian AS, Santamore WP. Importance of intraluminal pressure on hemodynamics and vasoconstriction responses of stenotic arteries. Circ Res 1992;85:708-16.
136. Gillespie MN, Booth DC, Friedman BJ, Cunningam MR, Jay M, DeMaria AN. fMLP provokes coronary vasoconstriction and myocardial ischemia in rabbits. Am J Physiol 1988;254:H481-6.
137. Ginsberg MD, Busto R. Rodentmodels of cerebral ischemia. Stroke 1989;20:1627-42.
138. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis. Arch Pathol Lab Med 1988:112:1018-31.
139. GodfraindT, Menning D, Morel N, Wibo M. Effect of endothelin-1 on calcium channel gating by agonists in vascular smooth muscle. J Cardiovasc Pharmacol 1989;13(suppl 5): 112-7.
140. Goetz EJ, Woods JM, Gorman RR. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosa-tetraenoic acid. J Clin Invest 1977:59:179-83.
141. Golino P, Capelli-Bigazzi M, Ambrosio G, Ragni M, Russolillo E, Condorelli M, Chiariello M. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation. Circ Res 1992;71:1447-56.
142. Golino P, Willerson JT, Ambrosio G, Pascucci I, Triggiani M, Ragni M, Russolino M, Chiarello M. Plateletactivating factor is a mediator of cyclic flow reductions in stenotic rabbit carotid arteries with endothelial injury. Circulation 1991;84(suppl II):II689.
143. Gonzales J, Mehta JL, Lawson DI, Nichols WW, Nicolini FA. Variable effects of human and canine polymorphonuclear leukocytes on vascular smooth muscle tone. Cardiovasc Res 1992;26:751-6.
144. Grabowski EF. Platelet aggregation in flowing blood at a site of injury to an endothelial cell monolayer. Blood 1990;75:390-8.
145. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:H 1275-5.
146. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukocyte Bio! 1994;55:662-75.
147. Granger DN, Kvietys PR, Perry MA. Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion. Can J Physiol Pharmacol 1993;71:67-75.
148. Grau AJ, Berger E, Sung KL, Schmid-Schonbein GW. Granulocyte adhesion, deformability, and Superoxide formation in acute stroke. Stroke 1992;23:33-9.
149. Greenberg DA, Chan J, Sampson HA. Endothelins and the nervous system. Neurology 1992;42:25-31.
150. Grogaard B, Schurer L, Gerdin B, Arfors KE. Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes. J Cereb Blood Flow Metab 1989;9:500-5.
151. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endotheliumderived relaxing factor. Nature 1986;320:454 -6.
152. Gunter J, Dhein S, Rosen R, Klaus W, Fricke U. Nitric oxide (EDRF) entrances the vasorelaxing effects of nitrendipine in various isolated arteries. Basic Res Cardiol 1992;87:452-60.
153. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neural 1990;47:1245-54.
154. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, Obrenovich TP, Contreras T. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 1986; 17:246-53.
155. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets and neutrophils. Blood 1990;75:55(M.
156. Hammerschmidt DE, Greenburg CS, Yamada O, Craddock P, Jacob HR. Cholesterol and ateroma activate complement and stimulate granulocytes. J Lab Clin Med 1981;98:68-77.
157. Harada T, Suzuki Y, Satoh S, Ikegaki I, Asano T, Shibuya M, Sugita K. Blood component induction of cerebral vasospasm. Neurosurgery 1990;27:252-5.
158. Harlan JM. Neutrophil-mediated vascular injury. Acta MedScand 1987;715(suppl): 123-9.
159. Harlan JM, Killen PD, Harker LA, Striker GE. Neutrophil-mediated endothelial injury in vitro. Mechanisms of cell detachment. J Clin Invest 1981 ;68:1394-403.
160. Harrison MJ. Role of platelets and antiplatelet agents in cerebrovascular disease. Circulation 1990;61(suppl 1):120-1.
161. Hatake K, Kakishita E, Wakabayashi I, Sakaiyama N, Hishida S. Effects of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 1990:21:1039-43.
162. Heistad DD, Brese K, Armstrong ML. Cerebral vasoconstrictor responses to serotonin after dietary treatment of atherosclerosis: implications to transient ischémie attacks. Stroke 1987;18:1068-73.
163. Heller RF, Bussolino F, Ghigo D, Garbarino G, Pescarmona G, Till U, Bosia A. Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochem Pharmacol 1992:44:223-9.
164. Heye N, Campos A, Kannuki S, Cervos-Navarro J. Effects of triflusal and acetylsalicylic acid on microthrombi formation in experimental brain ischemia. Exp Palhol 1991;41:31-6.
165. Heye N, Paetzold C, Cervos-Navarro J. The role of microthrombi and microcirculatory factors in localization and evolution of focal cerebral ischemia. Neurosurg Rev 1991; 14:7-16.
166. Higgins D, Santamore WP, Wallinsky P, Nemir P. Hemodynamics of human arterial stenoses. Int J Cardiol 1985:8:177-92.
167. Hirafuji M, Shinoda H. PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes. J Lipid Mediators 1991 ;4:347-51.
168. Hirafuji M, Shinoda H. Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro. BrJ Pharmacol 1993; 109:524-9.
169. Hirashima Y, Endo S, Otsuji T, Karasawa K, Nojima S, Takaku A. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1993:78:592-7.
170. Hiroaki S, Hashiro U, Hisanobu S, Kazuyoshi K, Motohatsu F. Endothelium-dependent contraction induced by platelet-derived substances in canine basilar arteries. J Pharmacol Exp Ther 1990:255:182-6.
171. Honma Y, Clower BR, Haining JL, Smith RR. Comparison of intimai platelet accumulation in cerebral arteries in two experimental models of subarachnoid hemorrhage. Neurosurgery 1989;24:487-90.
172. Hornstra G, Ten Hoor F. The filtragometer: a new device for measuring platelet aggregation in venous blood in man. Thromb Diath Haemorrh 1975;34:531-4J2.
173. Hossmann E, Hossmann K-A, Takagis S. Effect of intravascular platelet aggregation or blood recirculation following prolonged ischemia of the cat brain. J Neural 1980;222:159-70.
174. Hossmann K-A. Experimental aspects of stroke. In: Ross Rüssel R, ed. Vascular disease of the central nervous system. Edinburgh: Churchill Livingstonc, 1983:73-100.
175. Houston DS, Robinson P, Gerrard JM. Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cells. Blood 1990:76:953-8.
176. Houston DS, Shepherd JT, Vanhoutte PM. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of canine coronary arteries. J Clin Invest 1986;78:539-44.
177. Hutchison KJ. Endothelial cell morphology around graded stenoses of the dog common carotid artery. Blood Vessels 1991:28:396-4106.
178. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992;69:11-25.
179. Imig JD, Gebremedhin D, Harder DR, Roman RJ. Modulation of vascular tone in renal microcirculation by erythrocytes: role of EDRF. Am J Physiol 1993;264:H190-5.
180. Inauen W, Granger DN, Meininger CJ, Schelling CJ, Granger HJ, Kvietys PA. Anoxiareoxygenation-induced, neutrophil-mediated endothelial cell injury. Role of elastase. Am J Physiol 1990;259:H925-31.
181. Ito BR, Roth DM, Engler RL. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs. Circ Res 1990;66:596-607.
182. Jafar JJ, Menoni R, Feinberg H, LeBreton G, Crowell RM. Selective platelet deposition during focal cerebral ischemia in cats. Stroke 1989;20:664-7.
183. Janoff A. Elastase in tissue injury. Annu Rev Med 1985;36:207-16.
184. Jorgensen L, Grothe AG, Larsen T, Kinlough-Rathbone RL, Mustard JF. Injury of cultured cells by thrombin-stimulated platelets. Lab Invest 1986;54:408-12.
185. Joseph R, D'Andréa G, Oster SB, Welsh KM. Whole blood platelet function in acute ischémie stroke. Importance of dense body secretion and effects of antithrombotic agents. Stroke 1989;20:38-4t4.
186. Joseph R, Tsering C, Grunfeld S, Welsh KM. Platelet secretory products may contribute to neuronal injury. Stroke 1991;22:1448-51.
187. Jungi TW, Spycher MO, Nydegger UE, Barandun S. Platelet-leukocyte interaction: selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes, and related cell lines. Blood 1986;67:629-36.
188. Kamitani T, Katsula K, Sakai S. Protective effect of FR35477 on experimental cerebral infarction. Arch Int Pharmacodyn Ther 1984;272:264-6.
189. Kanamaru K, Waga S, KojimaT, Fujimoto K, Niwa S. Endothelium-dependent relaxation of canine basilar arteries: inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 1987;l8:938-43.
190. Kanamaru K, Weir BKA, Findlay JM, Krueger CA, Cook DA. Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. JNeurosurg 1989;71:909-15.
191. Karck M, Haverich A. Nifedipine and diltiazem reduce pulmonary edema formation during postischemic reperfusion ofthe rabbit lung. Res Exp Med 1992;192:137-44.
192. Kassel NF, Sasaki T, Colohan ART, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562-72.
193. Katayama Y, Terashi A, Shimizu J, Suzuki S, Kashiwagi F, KamiyaT, Ashida S. Role of platelets as a factor aggravating cerebral ischemia. Jpn Circ J 1990;54:1511-6.
194. Katusic ZS. Endothelial L-arginine pathway and regional cerebral arterial reactivity to vasopressin. Am J Physiol 1992;262:H1557-1562.
195. Katusic ZS, Marshall JJ, Kontos HA, Vanhoutte PM. Similar responsiveness of smooth muscle ofthe canine basilar artery to EDRF and nitric oxide. Am J Physiol 1989;257:H1235-9.
196. Kaul S, Heistad DD, Mugge A, Armstrong ML, Piegors DJ, Lopez AG. Vascular responses to platelet activation in normal and atherosclerotic primates. Arterioscler Thromb 1991 ; 11:1745-51.
197. Kaul S, Padgett RC, Waack BJ, Brooks RM, Heistad DD. Effect of atherosclerosis on responses ofthe perfused rabbit carotid artery to human platelets. Arterioscler Thromb 1992; 12:1206-13.
198. Kaul S, Waack BJ, Padgett RC, Brooks RM, Heistad DD. Altered vascular responses to platelets from hypercholesterolemic humans. Circ Res 1993;72:737-43.
199. Kessler C, Kelly AB, Suggs WD, Weissman JD, Epstein CM, Hanson SR, Harker LA. Induction of transient neurological dysfunction in baboons by platelet microemboli. Stroke 1992;23:697-702.
200. Kifor I, Dzau VJ. Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion ofangiotensis. Circ Res 1987;60:422-8.
201. Kim JA, Territo MC, Wayner E, Parhami CF, Smith CW, Haberland ME, Fogelman AM, Berliner JH. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. AtherosclerThromb 1994; 14:427-33.
202. Kirn YD, Danchak RM, Heim KF, Lees DE, Myers AK. Constriction of canine coronary arteries by platelet activating factor after brief ischemia. Prostaglandins 1993;46:269-76.
203. Kirn YD, Fomsgaard JS, Heim KF, Ramwell PW, Thomas G, Kagan E, Moore SP, Coughlin SS, Kuwahara M, Analouei A, Myers AK. Brief ischemia-reperfusion induces stunning of endothelium in canine coronary artery. Circulation 1992;85:1473-82.
204. Kirchengast M, Rubsamen K, Lehmann HD. Inhibition ofthe combined Ca2+ and 5-HT2 receptor antagonist nexopamil of intracoronary thrombus formation in a canine model of arterial stenosis and intimai damage. J Cardiovasc Pharmacol 1993;22:687-94.
205. Kishi Y, Numano F. In vitro study of vascular endothelial injury by activated platelets and its prevention. Atherosclerosis 1989;76:95-101.
206. Kling D, Holzschuh T, Betz E. Recruitment and dynamics of leukocytes in the formation or arterial intimai thickening-a comparative study with normo- and hypercholesterolemic rabbits. Atherosclerosis 1993;101:76-96.
207. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991;84:1758-72.
208. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992;23:1367-79.
209. Kojda G, Klaus W, Werner G, Fricke V The influence of endothelium on thé action of PGF and some dihydropyridine-type calcium antagonists in porcine basilar arteries. Basic Res Cardiol 1991;86:254-65.
210. Komatsu H, Nagasawa M, Okumoto T. Inhibition of leukocyte adhesion to endothelial cells of human umbilical vain by Y-24180, an antagonist of platelet-activating factor. Inl J Immunopharmacol 1993;15:737-44.
211. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels 1990;27:238-415.
212. Kontos HA. Nitric oxide and nitrosothiols in cerebrovascular and neuronal regulation. Stroke 1993;24(suppl 1): 155-8.
213. Kooy NW, Royall JA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys 1994;310:352-9.
214. Kornecki E, Ehrlich YH. Neuroregulatory and neuropathological action of the ether-phospholipid plateletactivating factor. Science 1988;240:1792-4.
215. Ku DD. Coronary vascular reactivity after myocardial ischemia. Science 1982;218:576-8.
216. Kubes P, Suzuki M, Granger DN. Modulation of PAF-induced leukocyte adhesion and increased microvascular permeability. Am J Physio/ 1990;258:G859-64.
217. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl AcadSciUSA 1991;88:4651-5.
218. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN. Inhibition of nitric oxide production. Mechanism of vascular albumin leakage. Circ Res 1993;73:164-71.
219. Laghi PF, Ceccatelli L, Pasqui AL, Orrico A, Capecchi PL, Di Perri T. Platelet-dependent granulocyte activation in vitro: effect of ticlopidine. Int J Tissue React 1985;7:367-72.
220. Lee DKH, Faunce D, Henry D, Sturm RJ, Rimele T. Neutrophil-derived relaxing factor relaxes vascular smooth muscle through a cGMP-mediated mechanism. Life Sei 1990;6:1531-8.
221. LeferAM, Ma XL. Cytokines and growth factors in endothelial dysfunction. Cri t Care Med 1993;21(suppl 2):S9-14.
222. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johanson J. Antineutrophil and myocardial protecting action of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993;88:2337-50.
223. LeferAM, Siegfried MR, Ma X. Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol 1993;22(suppl 7):S27-33.
224. Leffler CW, Mirro R, Armstead WM, Busija DW, Thelin O. Prostanoid synthesis and vascular responses to exogenous arachidonic acid following cerebral ischemia in piglets. Prostaglandins 1990;40:241-8.
225. Lerman A, Hildebrand FL, Marquies KB. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin Proc 1990;65:1441-55.
226. Levy BI, Fertak L, Pieddeloup C, Barouki F, Safar ME. Role of endothelium in the mechanical response to the carotid arterial wall to calcium blockade in spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 1993;! 1:57-63.
227. Levy R, Dana R, Gold B, Alkan M, Schaeffer F. Influence of calcium channel blockers on polymorphonuclear leukocytes and monocyte bacterial and fungicidal activity. IsrJMedSci 1991;27:301-6.
228. Li KS, Santamore WP, Morley DL, Tulemko TN. Stenotic amplification of vasoconstriction responses. Am JPhysiol 1989;256:H 1044-51.
229. Lindstrom P, Lerner R, Palmblad J, Pataroyo M. Rapid adhesive responses of endothelial cells and neutrophils induced by leukotriene B4 are mediated by leukocyte adhesion protein CD 18. Scand J Itnmunol 1990;31:737-45.
230. Liu JJ, Chen JR, Wiley J, Johnston CC, Buxton BF. Inhibition by a stable factor derived from neutrophils of endothelium-dependent relaxation in rat aorta. Am J Physiol 1993;265:H1454-9.
231. Lopez JAG, Armstrong ML, Harrison DG, Piegors DJ, Heistad DD. Vascular responses to leukocyte products in atherosclerotic primates. Circ Res 1989:65:1078-86.
232. Lopez OT, Lanthorn TH. Anti-neutrophil antiserum reduces infarct volume after mouse permanent middle cerebral artery occlusion without producing neutropenia. Neurosci Rex Commun 1993;13:45-53.
233. Lorant DE, Patel KD, Mclntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991;! 15:223-34.
234. Lucchesi BR. Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke 1993;24(suppl I):41-9.
235. Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced myocardial injury. Annu Rev Pharmacol Toxicol 1986;26:201-4.
236. Lusher TF. Angiotensin, ACE inhibitors and endothelial control of vasomotor tone. Basic Res Cardiol 1993;88(suppl 1): 15-24.
237. Lusher TF, Yang Z. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle. Drugs 1993;46(suppl 2):121-32.
238. Lusher TF, Yang Z, Tschudi M, von Segesser L, Stulz R Boulanger C, Siebenmann R, Turina M, Buhler FR. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990;66:1088-94.
239. Lynch JM, Lother GZ, Betz SJ. The release of a platelet-activating factor by stimulated rabbit neutrophils. J /mmuno/1979; 123:1219-26.
240. Ma X, Tsao PS, Viehman GE, Lefer AM. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfusion cat coronary artery. Circ Res 1991;69:95-106.
241. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-12.
242. Mac Alpin RN. Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction. Circulation 1980;61:296-301.
243. Maclouf J, Murphy R, Henson PM. Transcellular biosynthesis of sulfidopeptide leukotrienes during receptor-mediated stimulation of human neutrophil/platelet mixture. Blood 1990;76:1838-44.
244. Marcus AJ, Safier LB, Hajjar KA. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. J Clin Invest 1991;88:1690-6.
245. Maseri A, Davies G, Hackett D, Kaski JK. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990;81:1983-91.
246. Mason RP. Membrane interaction of calcium channel antagonists modulated by cholesterol. Biochem Pharmacol 1993;45:2173-83.
247. Masuda J, Ogata J, Yutani C, Miyashita T, Yamaguchi T. Artery-to-artery embolism from a thrombus formed in stenotic middle cerebral artery. Stroke 1987;18:680-4.
248. Mayhan WG. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. AmJPhysiol 1990;259:H1455-62.
249. Mayhan WG. Effect of diabetes mellitus on responses of the basilar artery in rats to products released by platelets. Stroke 1992;23:1499-503.
250. Mayhan WG, Amundsen SM, Faraci FM, Heistad DD. Responses of cerebral arteries after ischemia and reperfusion in cats. Am J Physiol 1988;24:H879-84.
251. McCalden TA, Nath RG. Hypercholesterolemia and the response of the rabbit ear and basilar artery to biogenie amines. Proc West Pharmacol Soc 1984;27:411-3.
252. McCord JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc 1987;46:2402-6.
253. McEver RP. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991 ;45:156-61.
254. Medell RS. Endothelial dysfunction and vascular disease. Am J Med Sei 1994;307:378-89.
255. Mehta JL, Lawson DL, Nicolini FA, Ross MH, Player DW. Effects of activated polymorphonuclear leukocytes on vascular smooth muscle tone. Am J Physiol 1991;261:H771-7.
256. Mehta JL, Nicolini FA, Donelly WH, Nichols WW. Platelet-leukocyte-endothelial interactions in coronary artery disease. Am JCofej/1992;69:8B-13B.
257. Mehta P, Mehta JL, Lawson D, Krop J. Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet aggregation. Thromb Res 1986;41:731-8.
258. Merhi Y, Lam JYT, Lacoste LL, Latour J-G, Guidoin R, Waters D. Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. Atheroscler Thromb 1993;13:951-7.
259. Mikkola T, Ristimaki A, Viinikka L, Ylikorkala O. Human serum, plasma and platelets stimulate prostacyclin and endothelin-1 synthesis in human vascular endothelial cells. Life Sei 1993;53:283-9.
260. Milhoan KA, Lane TA, Bloor CM. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. Am J Physiol 1992;263:H956-62.
261. Millikan C. Animal stroke models. Stroke 1992;23:795-7.
262. Minami N, Tani E, Yokota M, Maeda Y, Yamamura I. Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm. Acta Neuropathol 1991;84:401-7.
263. MitsuhiroY, Sakamoto S, Kusui A, Akita H, Maekawa K, Fukuzaki H. Effects of nifedipine on coronary vasculature in canine models of dynamic and fixed coronary stenoses. J Pharmacol Exp Ther 1985;233:845-52.
264. Mizer LA, Weisbrode SE, Dorinsky PM. Neutrophil accumulation and structural changes in nonpulmonary organs after acute lung injury induced by phorbol myristate acetate. Am Rev Respir Dis 1989; 139:1017-26.
265. Mollace Y Salvemini D, Sessa WC, Vane JR. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols. J Pharmacol ExpTher 1991;258:820-3.
266. Moncada S, Palmer R, Higgs AE. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
267. Morgan KG, De Feo T, Wenc K, Weinstein R. Alterations of excitation-contraction coupling by plateletderived growth factor in enzymatically isolated and cultured vascular smooth muscle cells. Pflugers Arch 1985:405:77-9.
268. Mori E, del Zoppo GJ, Chambers JD, Copeland BR, Arfors KE. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992;23:712-8.
269. Morikawa E, Moskowitz MA, Huang Z, Yoshida T, Irikura K, Dalkara T. L-Arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 1994;25:429-35.
270. Moritoki H, HisayamaT, Takeuchi S, Miyano H, Kondoh W. Involvement of nitric oxide pathway in the PAFinduced relaxation of rat thoracic aorta. BrJ Pharmacol 1992; 107:196-201.
271. Mugge A, Heistad DD, Padgett RC, Waack BJ, Densen P, Lopez AG. Mechanisms of contraction induced by human leukocytes in normal and atherosclerotic arteries. Circ Res 1991;69:871-80.
272. Mugge A, Lopez AG. Do leukocytes have a role in hypertension? Hypertension 1991;17:331-3.
273. Mullane K. Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc Med 1991; 1:282-9.
274. Mullane KM, Salmon JA, Kraemer R. Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Fed Proc 1987;46:2422-33.
275. Murohara T, Kugiyama K, Sugiyama S, Ohgushi M, Yasue H. Activated human polymorphonuclear leukocytes elicit endothelium-dependent contraction in isolated pig coronary arteries. J Cardiovasc Pharmacol 1993;21:760-6.
276. Nakagawa H, IsakaY, NakajimaY, FurutaY, Uchara A, Matsumoto M, Kimura K. Multiple cerebral infarcts caused by emboli from carotid atheroma-a case confirmed by indium-111 platelet scintigraphy. Neural Med Chir(Tokyo) 1991;31:159-61.
277. Nakagomi T, Kassell NF, Sasaki T, Fujiwara S, Lehman RM, Torner JC. Impairment of endothelium-dependent vasodilation induced by acetylcholine and adenosine triphosphate following experimental subarachnoid hemorrhage. Stroke 1987; 18:482-9.
278. Nakamura S, Yoshida K, Tsubokawa T. Regional disparity in the vascular response to subarachnoid hemorrhage: relationship between alteration of the concentration of eicosanoids and electron microscopic findings. Neural Med Chir (Tokyo) 1989;29:181-6.
279. Nakano S, Kogure K, Fujicura H. Ischemia-induced slowly progressive neuronal damage in the rat brain. Neuroscience 1990;38:115-24.
280. Nakayama N, Ikezono K, Yabuuchi Y Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro. Arzneimittelforsh 1993:43:1266-9.
281. Nalini K, Andrabi KI, Ganguly NK, Wahi PL. Nifedipine impairs neutrophil respiratory burst by a mechanism other than calcium channel blockade. Mol Cel Biochem 1990;93:27-34.
282. Nathan CF. Neutrophil activation on biological surfaces. J Clin Invest 1987:80:1550-60.
283. Nayler WG. Calcium channels and their involvement in cardiovascular disease. Biochem Pharmacol 1992:43:39-46.
284. Nazar GB, Kassell NF, Povlishok JT, Lee J, Hudson S. Subarachnoid hemorrhage causes adherence of white blood cells to the cerebral arterial luminal surface. In: Wilkins RH, ed.Cerebm/ angiospasm. New York: Raven Press, 1988:343-56.
285. Nishida M, KuzuyaT, Hoshida S, Youngjoon K, Kitabatake A, Kamada T, Tada M. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res 1990:60:253-8.
286. Nishimura H, Rosenblum WL, Nelson GH, Boynton S. Agents that modify EDRF formation alter antiplatelet properties of brain arteriolar endothelium in vivo. Am J Physiol 1991 ;261 :H 15-21.
287. Nordlander R, Orinius E. Ergonovine testing in patients with exertional angina. Acta Med Scand 1987:221:47-52.
288. Obrenovitch TP, Hallenbeck JM. Platelet accumulation in regions of low blood flow during the postischemic period. Stroke 1985; 16:224-34.
289. O'Flaherty J, Cousart S, Lineberger A, Bond E. Bass D, Dechatelet L, Leake E, Mccall C. Phorbol myristate acetate. In vivo effects upon neutrophils, platelets, and \ang.Am J Pat hoi 1980:101:79-92.
290. Ogata J, Masuda J, Yutani C, Yamaguchi T. Rupture of atheromatous plaque as a cause of thrombotic occlusion of stenotic internal carotid artery. Stroke 1990;21:1740-5.
291. Ohkuma H, Ogane K, Fujita S, Manabe H, Suzuki S. Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage. Stroke 1993;24:1541-6.
292. Ohkuma H, Suzuki S, Kimura M, Sobata E. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1991;22:854-9.
293. Ohlstein EH, Nichols AJ. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Ci re Res 1989;65:917-24.
294. Onoda JM, Sloane BF, Honn KV Antithrombotic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors. Thromb Res 1984;34:367-78.
295. Onoue H, Kaito N, Tokudome S, Abe T, Tashibu K, Nagashima H, Nakamura N. Investigation of postmortem functional changes in human cerebral arteries. J Cereb Blood Flow Metab 1993; 13:346-9.
296. Otsuki Y, Kondo T, Shio H, Kameyama M, Koyama T. Platelet aggregability in cerebral thrombosis-analyzed for vessel stenosis. Stroke 1983;14:368-71.
297. Padgett RC, Heistad DD, Mugge A, Armstrong ML, Piegors DJ, Lopez JAG. Vascular responses to activated leukocytes after regression of atherosclerosis. Circ Res 1992;70:423-9.
298. Palmblad J, Lerner R. Mechanisms for leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils: relation to CD54. Clin Exp Immunol 1992;90:300-7.
299. Palmblad J, Lerner R, Larsson SH. Signal transduction mechanisms for leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils. J Immunol 1994; 152:262-9.
300. Palmblad J, Lindstrom P, Lerner R. Leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils. Biochem Biophys Res Commun 1990;166:848-59.
301. Passero S, Battistini N, Fieshi C. Platelet embolism in rabbit brain. Stroke 1981;12:781-6.
302. Patel KJD, Zimmerman GA, Prescott SM, McEver RP, Mclntyre TM. Oxygen radicals induced human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991 ;112:749-59.
303. Patterson CE, Jin N, Packer CS, Rhoades RA. Activated neutrophils alter contractile properties of the pulmonary artery. Am J Respir Cell Mol Biol 1992;6:260-9.
304. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiarello M, Bach R, Garen A, Königsberg WK, Ezekowitz MD. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994;74:56-63.
305. Permian MB, Johnson A, Jubiz W, Malik AB. Lipoxygenase products induce neutrophil activation and increase endothelial permeability after thrombin-induced pulmonary microembolism. Circ Res 1989;64:62-73.
306. Perry I,.Buttrum SM, Nash GB. Effect of activation on adhesion of flowing neutrophils to cultured endothelium: time course and inhibition by a calcium channel blocker (nitrendipine). Br J Pharmacol 1993; 110:1630-4.
307. Petite CK. Platelet thrombi in experimental cerebral infarction. Stroke 1979;10:192-5.
308. Phan SH, Gannon DE, Varani J, Ryan US, Ward PA. Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. AmJPathol 1989:134:1201-11.
309. Pickard JB, Graham DI, Matear E, Macpherson P, Tamura A, Fitch W. Ultrastructure of cerebral arteries following experimental subarachnoid hemorrhage. J Neural Neurosurg Psychiatry 1985;48:256-62.
310. Pinch C, Luppattelli I, Keiler A, Gerakakis A, Angelberg P, Sinzinger H. Concomitant aspirin treatment abolishes the antiatherosclerotic effects of the calcium channel blocker isradipine mediated by PGI. Agents Actions 1992;37:242-58.
311. Pollanen MS, Deck JH. The mechanisms of embolie watershed infarction: experimental studies. Can J Neuro/Sc/1990;17:395-8.
312. Povishock JT, Rosenblum WI. Injury of brain microvessels with a helium-neon laser and Evans blue can elicit local platelet aggregation without endothelial denudation. Arch Pathol Lab Med 1987;! 11:415-21.
313. Radomski WM, Palmer RMJ, Moncada S. The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. BrJ Pharmacol 1987;92:639-4t6.
314. Radomski WM, Palmer RMJ, Moncada S. An L-arginine:nitric oxide pathway present in human platelets regulates aggregation. Proc NatlAcadSci USA 1990;87:5193-7.
315. Rafflenbeul W, Lichten PR. Zum konzept der "dynamischen" koronarsteins. ZKardiol 1982;71:439-44.
316. Redl H, Hammerschmidt D, Schlag G. Augmentation by platelets of granulocyte aggregation in response to chemotaxins: studies utilizing an improved cell preparation technique. Blood 1983;61:125-31.
317. Reininger AJ, Reininger CB, Wurzinger LJ. The influence of fluid dynamics upon adhesion of ADP-stimulated human platelets to endothelial cells. Thromb Res 1993;71:245-9.
318. Renesto P, Tahar MS, Chignard M. Modulation by Superoxide anions of neutrophil-mediated platelet activation. Biochem Pharmacol 1994;47:1401-4.
319. Reymenants E, Yang B, Nicolini F, Behrens P, Lawson D, Mehta JL. Verapamil and aspirin modulate plateletmediated vasomotion in arterial segments with intact or disrupted endothelium. J Am Coll Cardiol 1993;22:684-9.
320. Reynolds JM, McDonagh PF. Platelets do not modulate leukocyte-mediated coronary microvascular damage during early reperfusion. Am J Physio! 1994;266:H 171-81.
321. Rimele TJ, Armstrong SJ, Grimes D, Sturm RJ. Rat peritoneal neutrophils selectively relax vascular smooth muscle. JPharmacol Exp Ther 1991;258:963-71.
322. Rosenblum WI, Murata S, Nelson GH, Werner PK, Ranken R, Harman RC. Anti-CD31 delays platelet adhesion/aggregation at sites of endothelial injury in mouse cerebral arterioles. Am J Pathol 1994; 145:33-6.
323. Rothwell NJ, Relton JK. Involvement of interleukin-1 and lipocortin-1 in ischémie brain damage. Cerebrovasc Brain Metah Reviews 1993;5:178-98.
324. Rowe GG, Foils JD. Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease. Clin Cardia/ 1990;13:165-70.
325. Rubanyi GM. Endothelium, platelets, and coronary vasospasm. Coronary Artery Dis 1990;l:645-53.
326. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22(suppl4):Sl-14.
327. Rubanyi GM, Vanhoutte PM. Calcium and activation of release of endothelium-derived relaxing factors. Ann NYAcadSci 1988;522:226-31.
328. Sagach VF, Zhukova Ay Braquet P. Endothelium-dependent effects of platelet-activating factor in the coronary circulation. J Cardiovasc Pharmacol 1992;20(suppl 12):S85-9.
329. Saito T, Fushimi F, Abe T, Kimura Y, Takahashi K, ICudo Y, Nakagomi A, Miura M. Augmented contractile response to endothelin and blunted endothelium-dependent relaxation in post-ischemic reperfused coronary arteries. Jpn Circ J 1992;56:657-70.
330. Sakariassen KS, Fressinaud E, Girma JP, Meyer D, Baumgartner HR. Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen. Ann NY Acad Sei 1987;516:52-65.
331. Sala A, Rosson G, Buccellati C, Berti F, Folco G, Maclouf J. Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit. BrJPharmacol 1993;! 10:1206-12.
332. Salvemini D, de Nucci G, Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide like factor. Proc Nat! Acad Sei USA 1989;86:6328-32.
333. Salvemini D, de Nucci G, Sneddon JM, Vane JR. Superoxide anions enhance platelet adhesion and aggregation. BrJ Pharmacol 1989;97:1145-50.
334. Salvemini D, de Nucci G, Vane JR. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma. Thromb Haemost 1991:65:421-4.
335. Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane J. Nitric oxide: a regulatory mediator of mast cell reactivity. J Cardiovasc Pharmacol 1991 ; 17(suppl 3):S258-64.
336. Santamore WP, Wood JH, Bove AA, Lawner PM. Effects of vasoconstriction and distal dilation on carotid stenoses in the dog. Stroke 1983; 14:249-55.
337. Sasaki T, Wakai S, Asano T, Takakura K, Sano K. Prevention of cerebral vasospasm after SAH with thromboxane synthetase inhibitor, OKY-1581. JNeurosurg 1982;57:74-82.
338. Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Takamatsu S. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischémie stroke. Acta Neural Scand 1992;85:122-7.
339. Satoh S, Suzuki Y, Harada T, Ikegaki I, Asano T, Shibuya M, Sugita K, Saito A. The role of platelets in the development of cerebral vasospasm. Brain Res Bull 1991;27:663-8.
340. Schachter M. Do calcium antagonists affect platelets? Eur Heart J 1987;8(suppl):75-82.
341. Scheinberg P. The biologic basis for the treatment of acute stroke. Neurology 1991;41:1867-73.
342. Schror K.. Platelet reactivity and arachidonic acid metabolism in type II hypercholesterolemia and its modification by cholesterol-lowering agents: a review. Eicosanoids 1990;3:67-73.
343. Schuier FJ, Vise M, Hossmann K-A, Zulsh KJ. Cerebral microembolization. II. Morphological studies. Arch Neural 1978;35:264-70.
344. Schurer L, Grogaard B, Gerdin B, Arfors KE. Effects of neutrophil depletion and Superoxide dismutase on postischemic hypoperfusion in rat brain. Adv Neural 1990;52:57-62.
345. Schurer L, Grogaard B, Gerdin B, Kempski O, Arfors KE. Leukocyte depletion does not affect post-ischemic nerve cell damage in the rat. Acta Neurochir (Wien) 1991 ; 111:54-60.
346. Searle NR, Sahab P. Endothelial vasomotor regulation in health and disease. Can JAnaesth 1992;39:838-57.
347. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary micro- circulation of atherosclerotic primates. Circulation 1990;81:1586-93.
348. Semb AC, Ytrehus K., Vaage J, Myklebust R, Mjos OD. Functional impairment in isolated rat hearts induced by activated leukocytes: protective effect of oxygen free radical scavengers. J Mol Cell Cordial 1989;21:877-87.
349. Semeraro N, Locati D, Colucci M. Leukocyte-dependent platelet activation an alternative pathway for initiation of blood clotting in inflammation. Agents Actions 1981;! 1:553-5.
350. Sercombe R, Hardebo JE, Kahrstrom J, Seylaz J Amine-induced responses of pial and penetrating arteries: evidence for heterogeneous responses. J Cereb Blood Flow Metab 1990; 10:808-18.
351. Sercombe R, Verrecchia C. Role of vascular endothelium in modulating cerebrovascular effects of neurotransmitters. In: Owman C, Hardebo JE, eds. Neural regulation of brain circulation. Amsterdam: Elsevier, 1986:27-41.
352. Sercombe R, Verrecchia C, Miller MC, Seylaz J. Effect of high cholesterol diet on the reactivity of rabbit cerebral and peripheral arteries to amines. In: Seylaz J, Mackenzie ET, eds. Neurotransmission and cerebrovascularfimclion. Amsterdam: Elsevier, 1989:171-5.
353. Sercombe R, Verrecchia C, Oudart N, Dimitriadou V, Seylaz J. Pial artery responses to norepinephrine potentiated by endothelium removal. J Cereb Blood Flow Metab 1985;5:312-7.
354. Sercombe R, Verrecchia C, Philipson V, Oudart N, Dimitriadou V Bouchaud C, Seylaz J. Histamine-induced constriction and dilation of rabbit middle cerebral arteries in vitro: role of the endothelium. Blood Vessels 1986;23:137-53.
355. Sessa WC, Kaw S, Hecker M, Vane JB. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Rex Commun 1991; 174:613-8.
356. Sessa WC, Mullane KM. Release of neutrophil derived vasoconstrictor agent which augments platelet-induced contraction of blood vessels in vitro. BrJ Pharmacol 1990;99:553-9.
357. Shimokawa H, Kirn P, Vanhoutte PM. Endothelium-dependent relaxation to aggregating platelets in isolated basilar arteries of control and hypercolesterolemic pigs. Circ Res 1988;63:604-12.
358. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989:64:900-14.
359. Shirakura S, Sano J, Karasawa A, Kubo K. Protective effects of benidipine on arachidonic acid-induced acute cerebral ischemia in rats. Jpn J Pharmacol 1992;59:15-22.
360. Silbergleit A. A study of platelet-leukocyte aggregation in coronary thrombosis and cerebral thrombosis. Thromb Diath Haemorrh 1970; 17(suppl 42AD): 155-65.
361. Simpson PJ, Mickelson JK, Lucchesi BR. Free radical scavengers in myocardial ischemia. Fed Proc 1987;46:2413-21.
362. Sinzinger H. The role of prostacyclin in atherosclerosis. Pharmacol Res Commun 1988;20:71-83.
363. Smedley LA, Tonnesen MG, Sandhous RA, Rasiert C, Guthrie LA, Johnston RB, Henson PM, Worthen GS. Neutrophil-mediated injury to endothelial cells. J Clin Invest 1986;77:1233-413.
364. Smith CW, Anderson DC, Taylor AA. Leukocyte adhesion molecules and myocardial ischemia. Trends CardiovascMedl99\;\:\67-10.
365. Sobey CG, Dusting GJ, Stewart AG. Tumor necrosis factor alpha augments the release of an endotheliumdependent vasoconstrictor from human polymorphonuclear leukocytes. J Cardiovasc Pharmacol 1992;20:813-9.
366. Sobey CG, Woodman OL. Myocardial ischemia: what happens to the coronary arteries? Trend Pharmacol Sei 1993;14:448-53.
367. Soloviev AI, Braquet P. Platelet-activating factor induces contraction of saponin-skinned smooth muscle of coronary artery. Lipids 1991;26:1274-6.
368. Spector AA, Hoak JC. Fatty acids, platelets and microcirculatory obstruction. Science 1975; 190:490-1.
369. Srivastava KC. Effects of dipyridamole, nifedipine, verapamil, hydralazine and propranolol on the formation of prostacyclin and thromboxane in a coupled system of platelets and aorta. Prostaglandins Leukotrienes Afe/1986;23:31-6.
370. Stamler J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalo J. /V-Acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989;65:789-95.
371. Strony J, Beaudon A, Brands D, Adelman B. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 1993;265:H 1787-96.
372. Suzuki S, Kimura M, Souma M, Ohkuma H, ShimizuT, Iwabuchi T. Cerebral microthrombosis in symptomatic cerebral vasospasm-a quantitative histological study in autopsy cases. Neural Med Chir (Tokyo) 1990;30:309-16.
373. Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasm and delayed cerebral ischémie symptoms after subarachnoid hemorrhage due to aneurysmal rupture: a randomized double-blind study. Neural Res 1989;! 1:79-88.
374. Takeshima R, Kirsh JR, Koehler RC, Gomoll AW, Traystman RJ. Monoclonal leukocyte antibody does not decrease the injury of transient focal cerebral ischemia in cats. Stroke 1992;23:247-52.
375. Tanabe M, Terashita Z, Fujiwara S. Coronary circulatory failure and thromboxane A release during coronary occlusion and reperfusion in anesthetized dogs. Cardiovasc Res 1982;16:99-106.
376. TanigawaT, KotakeY, Reinke L. Spin trapping of Superoxide from glass adherent polymorphonuclear leukocytes induced by /V-formylmethionyl-leucyl-phenylalanine. Free Radical Res Commun 1993;19:101-10.
377. Tedgui A, Bernard C. Cytokines, immuno-inflammatory response and atherosclerosis. Eur Cytokine Netw 1994;5:263-70.
378. Thompson JA, Wei EP, Kontos HA. Inhibition by ketanserine of serotonin-induced cerebral arteriolar constriction. Stroke 1984; 15:1021 -4.
379. Toda N. Pharmacological assessment of cerebral and coronary vasospasm. Trends Pharmacol Sei 1985;6:85~7.
380. Toda N, Ayajiki K, OkamuraT. Cerebroarterial relaxations mediated by nitric oxide derived from endothelium and vasodilator nerve. J Vase Res 1993;30:61-7.
381. Toda N, Ayajiki K, OkamuraT. Endothelial modulation of contractions caused by oxyhemoglobin and Nnitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke 1993;24:1584-9.
382. Tohgi H, Suzuki H, Tamura K, Kimura B. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke 1991;22:17-21.
383. Toole JF. Cerebrovascular disorders. New York: Raven Press, 1984.
384. Torvik A. The pathogenesis of watershed infarcts in the brain. Stroke 1984; 15:221-3.
385. Tulenko TN, Canstantinescu D, Kikuchi T, Cox RH, Santamore WP. Mutual interactions of vasoconstriction and endothelial damage in stenotic arteries. Am J Physio/ 1989;265:H881-9.
386. Tzeng DY, Duel TF, Huang JS, Senior RM, Boxer LA, Bacher N. Platelet-derived growth factor promotes polymorphonuclear leukocyte activation. Blood 1984;64:1123-8.
387. Uhl MW, Kochanek PM, Schiding JK, Nemoto EM. Effect of phorbol myristate acetate on cerebral blood flow in normal and neutrophil-depleted rats. Stroke 1993;24:1977-82.
388. Ushida Y, Murao S. Role of prostaglandin I and thromboxane A in recurring reduction of carotid and cerebral blood flow in dogs. Stroke 1981;12:786-92.
389. Uski TK, Reinstruo P. Action of platelet-activating factor on isolated feline and human cerebral arteries. J Cereb Blood Flow Metab 1990; 10:428-31.
390. Vadas MA, Gamble JR. Regulation of the adhesion of neutrophils to endothelium. Biochem Pharmacol 1990:40:1683-7.
391. Valone FH. Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. Thromb Res 1987;45:427-35.
392. Vane JR, Anggard EE, Bolting RM. Regulatory function of vascular endothelium. N Engl J Med 1990;323:27-36.
393. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989;80:l-9.
394. Van Kooten F, Clabattoni G, Patrone C, Schmilz PIM, Gijn J, Koudslaal PJ. Evidence for episodic plalelel aclivalion in acule ischémie slroke. Stroke 1994;25:278-81.
395. Van Zanten GH, Graaf S, Slootweg PJ, Heijnen HFG, Connolly TM, de Groot PC, Sixma JJ. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest 1994;93:615-32.
396. Vasthare US, Heinel LA, Rosenwasser RH, Tuma RF. Leukocyle involvement in cerebral ischemia and reperfusion injury. Surg Neural 1990;33:261-5.
397. Vercellotti GM, Yin HQ, Guslafson KS, Nelson RD, Jacob HS. Plalelel-aclivaling factor primes neulrophil responses lo agonisls: role in promoting neutrophil-mediated endolhelial damage. Blood 1988;71:1100-7.
398. Verrecchia C, Sercombe R, Seylaz J. Vasoconstrictor responses influenced by the endolhelium. In: Vanhoutte PM, Vatner S, eds. Mechanisms of vasodilation III. New York: Karger, 1984:16-21.
399. Volkl K-P. A sensitive in vivo platelet function test in rats based on inlravenously injecled collagenase. Haemostasis 1989; 19:174-9.
400. Vrelhem M, Johansson I. Prognosis in palienls wilh Iransienl ischémie attacks and minor stroke associated with a normal angiogram. Eur Neural 1990;30:203-6.
401. Wahl M, Schilling L. Effects of bradykinin in the cerebral microcirculation. In: Phillis JW, ed.The regulation of cerebral blood flow. Boca Raton: CRC Press, 1993:315-28.
402. Wahl M, Schilling L. Mediators inducing stasis in cerebral microvessels during ischemia. In: Tomita M, ed. Microcirculatory stasis in the brain. Amsterdam: Elsevier, 1993:305-10.
403. Wai HM, Chi OZ, Liu X, Sinha AK, Weiss HR. Nitric oxide synthase inhibition alters cerebral blood flow and oxygen balance in focal cerebral ischemia in rals. Stroke 1994;25:445-50.
404. Wang P-Y, Kao C-H, Mui M-Y, Wang S-J. Leukocyle infiltration in acute hemispheric ischémie stroke. Stroke 1993;24:236-4W.
405. Ware JA, Heistad DD. Platelel-endothelium interaclions. N Engl J Med 1993;328:628-35.
406. Watanabe M, Yagi M, Omala M, Hirasawa N, Mue S, Tsurufuji S, Ohuchi K. Stimulation of neutrophil adherence lo vascular endolhelial cells by hislamine and Ihrombin and ils inhibilion by PAF anlagonisls and dexamelhasone. BrJ Pharmacol 1991;102:239-45.
407. Weiss SJ. Tissue destruclion by neulrophils. N Engl J Med 1989;320:365-76.
408. Wester P, Dietrich WD, Prado R, Watson BD, Globus MY-T. Serotonin release into plasma following common carolid artery Ihrombosis. Stroke 1992;23:870-5.
409. Wesllin WF, Gimbrone MA. Neulrophil-medialed damage lo human vascular endolhelium: role of cylokine aclivalion. Am J Pathol 1993;142:117-28.
410. Whatley RE, Nelson P, Zimmerman GA, Stevens DL, Parker TM, Mclntyre TM, Prescott SM. The regulation of platelet-activating factor production in endothelial cells: the role of calcium and protein kinase C. J BiolChem 1989;264:6325-33.
411. White RP. Responses of isolated cerebral arteries to vasoactive agents. Neumsurg Clin North Am 1990;1:401-15.
412. Wilkins RH. Cerebral vasospasm. Crit Rev Neurobiol 1990;6:51-77.
413. Willems S, Stel HV, vanAken WG, van Mourik JA. Binding and inactivation of prostacyclin by human erythrocytes. Br J Haemalol 1983;54:43-52.
414. Wintroub BU, Klickstein LB, Dzau VJ, Watt KWK. Granulocyte-angiotensin system: identification of angiotensinogen as plasma protein substrate of leukocyte catepsin G. Biochemistry 1984;23:227-32.
415. Wong MCW, Haley EC. Calcium antagonists: stroke therapy coming of age. Stroke 1990;21:494-501.
416. Wright LD, Mulch A, Busse R, Osswald H. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989;160:813-9.
417. Wurzunger LJ, Schmid-Schonbein H. The role of fluid dynamics in triggering and amplifying hemostatic reactions in thrombogenesis. Monogr Atheroscler 1990; 15:215-26.
418. Yabuta A. A study of collateral circulation in acute stage of occlusion of the middle cerebral artery. Nippon GekaHokan 1991;60:165-75.
419. Yaghi M, Watts JA. Effects of nisoldipine upon endothelial dysfunction following ischémie and reoxidative injury in the perfused rat heart. Cardiovasc Res 1993;27:99(M>.
420. Yamada Y, Yokota M, Furumichi T, Furui H, Yamauchi K, Saito H. Protective effects of calcium channel blockers on hydrogen peroxide reduced increases in endothelial permeability. Cardiovasc Res 1990;24:993-7.
421. Yamazaki H, Fujimoto T, Suzuki H, Akamatsu N, Katagiri Y, Yamaguchi A, Tanoue K. Interaction of platelets and blood vessels-vascular injuries induced by platelet activation in vivo. Jpn Cire J 1992;56:178-86.
422. Yang Z, Richard V, von Segesser L, Bauer E, Stulz P. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 1990;82:188-95.
423. Yao SK, Ober JC, Gonenne A, Clubb FJ, Krishnaswami A, Ferguson JJ, Anderson HV, Gorecki M, Buja LM, Willerson JT. Active oxygen spacies play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ Res 1993;73:952-67.
424. Zatta A, Prosdocimi M, Bettele V, Bazzoni G, Maschio A. Inhibition of platelet function polymorphonuclear leukocytes. J Lab Clin Med 1990;! 16:651-60.
425. Zellers TM, Shimokawa H, Yunginger J, Vanhoutte PM. Heterogenity of endothelium-dependent and endothelium-independent responses to aggregating platelets in pocine pulmonary arteries. Circ Res 1991;68:1437-45.
426. Zhang F, White JG, ladecola C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 1994; 14:217-26.
427. Zimmerman BJ, Granger DN. Reperfusion-induced leukocyte infiltration: role of elastase. AmJPhysiol 1990;259:H390~9.
428. Zimmerman GA, Mclntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990;! 10:529-440.
429. Zimmerman GA, Prescott SM, Mclntyre TM. Platelet-activating factor: a fluid phase and cell-associated mediator of inflammation. In: Gallin J, Goldstein IM, Snyderman R, eds. Inflammation. Basic principles and clinical correlates. New York: Raven Press, 1992:149-76.
430. Zimmermann JJ, Zuk SM, Millard JR. In vitro modulation of human neutrophil Superoxide anion generation by various calcium channel antagonists used in ischemia-reperfusion resuscitation. Biochem Pharmacol 1989;38:3601-10.
431. Zivin JA, Grotta JC. Animal stroke models. They are relevant to human aisease.Stroke 1990;21:981-3.
432. Zwiener U, Bauer R, Bergmann R, Eiselt M. Experimental and clinical main forms of hypoxic-ischemic brain damage and their monitoring. Exp Pathol 1991;42:187-96.